|
⚲
|
| Keyboard |
| RTW Investments LLC
✚
|
|
|---|---|
| CIK # | 0001493215 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Synta Pharmaceuticals Corp | 1.0 | ||
| Insmed Inc | 0.8 | ||
| Protagonist Therapeutics Inc | 0.5 | ||
| PTC Therapeutics Inc | 0.5 | ||
| Argenx SE | 0.5 | ||
| CG Oncology Inc | 0.5 | ||
| Celcuity Inc | 0.3 | ||
| BCTG Acquisition Corp | 0.3 | ||
| Erasca Inc | 0.3 | ||
| Natera Inc | 0.2 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001493215] | |
| 3 | [0001493215] | |
| 4 | [0001493215] | |
| SC 13D | [0001493215] | |
| SC 13G | [0001493215] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 991,544 | $1.67 | 1,655,878 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 96,896 | $1.67 | 161,816 |
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 767,848 | ||
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 991,544 | ||
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 96,896 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 767,848 | $1.67 | 1,282,306 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 37,863 | $3.35 | 126,841 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 631,954 | $3.35 | 2,117,046 |
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $126,839.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $126,839.00 | ||
|
Health Sciences Acquisitions Corp 2 OBIO
Pre-Funded Warrants (Right to Buy) · derivative
|
2025-08-04 | Buy | 3,636,363 | $2.75 | 9,999,998 |
|
Health Sciences Acquisitions Corp 2 OBIO
Common Stock
|
2025-04-30 | Buy | 49,900 | $2.99 | 149,201 |
|
Health Sciences Acquisitions Corp 2 OBIO
Common Stock
|
2025-04-29 | Buy | 50,000 | $2.53 | 126,500 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 37,863 | $3.35 | 126,841 |
| showing 20 of 151 most recent transactions | |||||